日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial Cancer

氯吡脲诱导子宫内膜癌的线粒体呼吸抑制和代谢转变

Kyukwang Kim, Negar Khazan, Rachael B Rowswell-Turner, Rakesh K Singh, Taylor Moore, Myla S Strawderman, John P Miller, Cameron W A Snyder, Ahmad Awada, Richard G Moore

Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies

靶向抑制素以抑制黑色素瘤生长并克服对靶向治疗的耐药性

Ahmad Najem, Mohammad Krayem, Serena Sabbah, Matilde Pesetti, Fabrice Journe, Ahmad Awada, Laurent Désaubry, Ghanem E Ghanem

PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer

三阴性乳腺癌中 PIK3CA 拷贝数增加和 PI3K/AKT/mTOR 通路抑制剂

Ottavia Amato, Laurence Buisseret, Géraldine Gebhart, Nicolas Plouznikoff, Denis Larsimont, Ahmad Awada, Martine Piccart, Philippe Aftimos

Predictors of all-cause mortality in hospitalized COVID-19 patients taking corticosteroids: a multicenter retrospective cross-sectional study

服用皮质类固醇的COVID-19住院患者全因死亡率的预测因素:一项多中心回顾性横断面研究

Mahmoud, Viviane; Hatem, Georges; Al-Saleh, Amani; Ghanem, Diana; Yassine, Ahmad; Awada, Sanaa

The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma

PARP-1 和 c-Met 联合靶向治疗对野生型 BRAF 黑色素瘤放射治疗疗效的益处

Malak Sabbah, Ahmad Najem, Christophe Vanderkerkhove, Fabien Kert, Younes Jourani, Fabrice Journe, Ahmad Awada, Dirk Van Gestel, Ghanem E Ghanem, Mohammad Krayem

First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

针对实体瘤患者的首个白细胞介素-1 受体辅助蛋白 (IL1RAP) 抗体 CAN04 的 1 期人体首次剂量递增研究

Debbie Robbrecht, Christiane Jungels, Morten Mau Sorensen, Iben Spanggaard, Ferry Eskens, Signe Ø Fretland, Tormod Kyrre Guren, Philippe Aftimos, David Liberg, Christer Svedman, Lars Thorsson, Neeltje Steeghs, Ahmad Awada

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance

瑞戈非尼诱导结直肠癌衰老和上皮-间质转化,促进耐药性

Pashalina Kehagias, Nadège Kindt, Mohammad Krayem, Ahmad Najem, Giulia Agostini, Elena Acedo Reina, Giacomo Bregni, Francesco Sclafani, Fabrice Journe, Ahmad Awada, Ghanem E Ghanem, Alain Hendlisz

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer

FDG 正电子发射断层扫描成像和 ctDNA 检测作为依维莫司治疗晚期腔内乳腺癌疗效的早期动态生物标志物

Andrea Gombos #, David Venet #, Lieveke Ameye, Peter Vuylsteke, Patrick Neven, Vincent Richard, Francois P Duhoux, Jean-Francois Laes, Françoise Rothe, Christos Sotiriou, Marianne Paesmans, Ahmad Awada, Thomas Guiot, Patrick Flamen, Martine Piccart-Gebhart, Michail Ignatiadis #, Géraldine Gebhart #3

Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value

酪氨酸依赖性表型转换在许多原发性黑色素瘤培养物中发生较早,限制了它们的转化价值

Ahmad Najem, Jasper Wouters, Mohammad Krayem, Florian Rambow, Malak Sabbah, François Sales, Ahmad Awada, Stein Aerts, Fabrice Journe, Jean-Christophe Marine, Ghanem E Ghanem

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance

激酶组分析可预测黑色素瘤对 MAPK 抑制的敏感性,并为内在和获得性耐药机制提供新见解

Mohamad Krayem, Philippe Aftimos, Ahmad Najem, Tim van den Hooven, Adriënne van den Berg, Liesbeth Hovestad-Bijl, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Malak Sabbah, Joseph Kerger, Ahmad Awada, Fabrice Journe, Ghanem E Ghanem